Back
Carasent AB 10K Form
Sell
19
APXZF
Carasent AB
Last Price:
$4.30
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive APXZF News And Ratings
See the #1 stock for the next 7 days that we like better than APXZF
APXZF Financial Statistics
Sales & Book Value
| Annual Sales: | $26M |
|---|---|
| Cash Flow: | $-898.5K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.21 |
| Price / Book: | 3.43 |
Profitability
| EPS (TTM): | 0.00610 |
|---|---|
| Net Income (TTM): | $443.5K |
| Gross Margin: | $3M |
| Return on Equity: | 0.5% |
| Return on Assets: | 0.42% |
Carasent AB Earnings Forecast
Key Carasent AB Financial Ratios
-
The Gross Profit Margin over the past 25 years for APXZF is 11.53%.
-
The Selling, General & Administrative Expenses for APXZF have been equal to 29.48% of Gross Profit Margin.
-
The Research & Development expenses have been 5.34% of Revenue.
-
The Net Earning history of APXZF is -15.35% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 16 years.
Carasent AB Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Technology |
| Sector: | Health Care |
| Current Symbol: | APXZF |
| Website: | carasent.com |
Debt
| Debt-to-Equity Ratio: | 0.04 |
|---|---|
| Current Ratio: | 2.2 |
| Quick Ratio: | 1.94 |
Price-to-Earnings
| Trailing P/E Ratio: | 3.7 |
|---|---|
| Forward P/E Ratio: | 0 |
APXZF Technical Analysis vs Fundamental Analysis
Sell
19
Carasent AB (APXZF)
is a Sell
Is Carasent AB a Buy or a Sell?
-
Carasent AB stock is rated a SellThe current Carasent AB [APXZF] share price is $4.30. The Score for APXZF is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.